2019

Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials

Lack of consensus in ALS genetic testing practices and divergent views between ALS clinicians and patients

High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis

2018

Abnormal RNA stability in amyotrophic lateral sclerosis

Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization

ALS specific quality of life- short form (ALSSQOL-SF): A brief, reliable and valid version of the ALSSQOL-R

Long-term Phase 1/2 intraspinal stem cell transplantation outcomes in ALS

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

Emerging understanding of the genotype-phenotype relationship in amyotrophic lateral sclerosis

Symptom management in amyotrophic lateral sclerosis: We can do better

2017

Complete hazard ranking to analyze right-censored data: An ALS survival study

Best practices protocol for the evaluation of bulbar dysfunction: summary recommendations from the NEALS bulbar subcommittee symposium

Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression

Diagnosis and clinical management of amyotrophic lateral sclerosis and other motor neuron disorders

Use of angle-independent M-mode sonography for assessment of diaphragm displacement

Speckle tracking as a method to measure hemidiaphragm excursion

2016

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

Transplantation of spinal cord-derived neural stem cells for ALS: Analysis of phase 1 and 2 trials

Increased ratio of circulating neutrophils to monocytes in amyotrophic lateral sclerosis

Screening for novel hexanucleotide repeat expansions at ALS- and FTD-associated loci

Association of environmental toxins with amyotrophic lateral sclerosis

Pearls & Oy-sters: The importance of atypical features and tracking progression in patients misdiagnosed with ALS

2015

Clinical trials of therapies for amyotrophic lateral sclerosis: one size does not fit all

Environmental risk factors and amyotrophic lateral sclerosis (ALS): A case-control study of ALS in Michigan

Dose escalation and safety study of human spinal cord derived neural stem cell transplantation for the treatment of amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era

Histological bulbar manifestations in the ALS rat

The spectrum of motor neuron diseases: From childhood spinal muscular atrophy to adult amyotrophic lateral sclerosis

Recent advances and the future of stem cell therapies in amyotrophic lateral sclerosis

The dual roles of immunity in ALS: injury overrides protection

Autocrine production of IGF-I increases stem cell-mediated neuroprotection